相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interleukin-6 predicts short-term global functional decline in the oldest old: results from the BELFRAIL study
Wim Adriaensen et al.
AGE (2014)
Potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment: a cross-sectional study
Shu-yang Yu et al.
BMC NEUROLOGY (2014)
Complex Deregulation and Expression of Cytokines and Mediators of the Immune Response in Parkinson's Disease Brain is Region Dependent
Paula Garcia-Esparcia et al.
BRAIN PATHOLOGY (2014)
Physical Exercise in MCI Elderly Promotes Reduction of Pro-Inflammatory Cytokines and Improvements on Cognition and BDNF Peripheral Levels
Carla Manuela Crispim Nascimento et al.
CURRENT ALZHEIMER RESEARCH (2014)
Glimepiride reduces CD14 expression and cytokine secretion from macrophages
Victoria Ingham et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Reduced Alpha-Synuclein in Cerebrospinal Fluid in Synucleinopathies: Evidence From a Meta-analysis
Wataru Sako et al.
MOVEMENT DISORDERS (2014)
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease
Oskar Hansson et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Cerebrospinal fluid inflammatory markers in Parkinson's disease - Associations with depression, fatigue, and cognitive impairment
Daniel Lindqvist et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
Malin Wennstrom et al.
PLOS ONE (2013)
The Diagnostic Value of CSF α-Synuclein in the Differential Diagnosis of Dementia with Lewy Bodies vs. Normal Subjects and Patients with Alzheimer's Disease
Elisabeth Kapaki et al.
PLOS ONE (2013)
NG2 cells, a new trail for Alzheimer’s disease mechanisms?
Henrietta M Nielsen et al.
Acta Neuropathologica Communications (2013)
Alpha-synuclein in the Cerebrospinal Fluid Differentiates Synucleinopathies (Parkinson Disease, Dementia With Lewy Bodies, Multiple System Atrophy) From Alzheimer Disease
Fuyuki Tateno et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2012)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study (vol 10, pg 230, 2011)
B. Mollenhauer et al.
LANCET NEUROLOGY (2011)
Cerebrospinal Fluid Tau/α-Synuclein Ratio in Parkinson's Disease and Degenerative Dementias
Lucilla Parnetti et al.
MOVEMENT DISORDERS (2011)
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
Brit Mollenhauer et al.
LANCET NEUROLOGY (2011)
Short communication Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease
T. Müller et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease
J. Kálmán et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Association Between Raised Inflammatory Markers and Cognitive Decline in Elderly People With Type 2 Diabetes The Edinburgh Type 2 Diabetes Study
Riccardo E. Marioni et al.
DIABETES (2010)
Association between male gender and cortical Lewy body pathology in large autopsy series
Peter T. Nelson et al.
JOURNAL OF NEUROLOGY (2010)
Differential levels of α-synuclein, β-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease
Kensaku Kasuga et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity
Daniel Lindqvist et al.
BIOLOGICAL PSYCHIATRY (2009)
CSF α-synuclein levels in dementia with Lewy bodies and Alzheimer's disease
Moeko Noguchi-Shinohara et al.
BRAIN RESEARCH (2009)
Systemic inflammation and disease progression in Alzheimer disease
C. Holmes et al.
NEUROLOGY (2009)
Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
Brit Mollenhauer et al.
EXPERIMENTAL NEUROLOGY (2008)
Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells
Masaya Nakanishi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers
Nathan L. Sparkman et al.
JOURNAL OF NEUROSCIENCE (2006)
Prenatal exposure to interleukin-6 results in hypertension and alterations in the renin-angiotensin system of the rat
Anne-Maj Samuelsson et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABAA dysregulation and impaired spatial learning
AM Samuelsson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop
Ian G. McKeith
JOURNAL OF ALZHEIMERS DISEASE (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Cerebrospinal fluid tau, Aβ1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia
JP Jia et al.
NEUROSCIENCE LETTERS (2005)
Aggregated α-synuclein activates microglia:: a process leading to disease progression in Parkinson's disease
W Zhang et al.
FASEB JOURNAL (2005)
Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity
YP Peng et al.
NEUROSCIENCE LETTERS (2005)
Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains
K Imamura et al.
ACTA NEUROPATHOLOGICA (2005)
Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices
M Pizzi et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2004)
Cerebrospinal fluid markers in dementia with Lewy bodies compared with Alzheimer disease
E Gómez-Tortosa et al.
ARCHIVES OF NEUROLOGY (2003)
Systemic infection, interleukin 1β, and cognitive decline in Alzheimer's disease
C Holmes et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Interleukin-6 and risk of cognitive decline - MacArthur studies of successful aging
JD Weaver et al.
NEUROLOGY (2002)
Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder
DG Baker et al.
NEUROIMMUNOMODULATION (2001)
Increased cerebrospinal fluid Fas (Apo-1) levels in Alzheimer's disease -: Relationship with IL-6 concentrations
M Martínez et al.
BRAIN RESEARCH (2000)
Synergistic effects of interleukin-1β, interleukin-6, and tumor necrosis factor-α:: Central monoamine, corticosterone, and behavioral variations
K Brebner et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies
CE Shepherd et al.
ARCHIVES OF NEUROLOGY (2000)
分享论文
